Clinical trials

  • BEROTRALSTAT for Hereditary angioedema
  • FINERENONE for Chronic kidney disease
  • AMG 193 for Thoracic tumors with homozygous MTAP-deletion | Non-small cell lung cancer
  • ALTEPLASE for Intermediate-high-risk acute pulmonary embolism | Pulmonary embolism
  • LEUPRORELIN ACETATE for Biochemical recurrence of prostate cancer | Oligometastatic prostate cancer (≤4 metastases)
  • SEVABERTINIB for Non-small cell lung cancer with HER2 (ERBB2) activating mutation
  • zongertinib for Non-small cell lung cancer | Solid tumours with HER2 aberrations
  • BRIGATINIB for Non-small cell lung cancer (ALK-positive)
  • ALECTINIB for Non-small cell lung cancer | Resectable stage I-III non-small cell lung cancer
  • SELINEXOR for Myelofibrosis | Thrombocytopenia
  • LY4170156 for Ovarian cancer | Endometrial cancer | Cervical cancer | Non-small cell lung cancer | Triple-negative breast cancer | Pancreatic cancer | Colorectal cancer
  • Acetylsalicylic acid for Breast cancer | Colon cancer | Rectal cancer | Stomach cancer | Oesophageal cancer | Prostate cancer